Glaukoma klinikiniai tyrimai Texas
8 tyrimai dėl Glaukoma ieško dalyvių vietose Texas.
Oficialus tyrimo tekstas (anglų kalba)
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07816692Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT04967989Rocklatan vs Latanoprost Post-DSLT
- Eye Centers of Southeast Texas, Beaumont
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT07465913Change in IOP Fluctuation After DSLT
- Ophthalmology Associates, Fort Worth
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-20 · NCT07428668Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Glaucoma Associates of Texas, Dallas
- University of Texas Southwestern, Dallas
Renkami dalyviai
Amžius 45 ir vyresni · Visoms lytims · Atnaujinta 2025-12-15 · NCT07220876Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Renkami dalyviai3 fazė
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Renkami dalyviai3 fazė
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT07218783Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.